ruxolitinib

Topical Ruxolitinib Therapeutic Cheat Sheet
Ruxolitinib
by Adam Rosenfeld, MD on
Ruxolitinib (OPZELURA) is a twice daily topical cream that is FDA approved for non-segmental vitiligo and mild to moderate atopic dermatitis1. JAK inhibitors are a class of drugs effective in treating a wide variety of inflammatory conditions. Initially only FDA approved for non-dermatologic conditions such as rheumatoid arthritis and ulcerative colitis, there is now strong evidence that JAK/STAT …

Continue reading "Topical Ruxolitinib Therapeutic Cheat Sheet"

Vitiligo Medical Treatment Advances | Expert Insights
vitiligo
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Amit Pandya, staff dermatologist with Palo Alto Foundation Medical Group and adjunct professor in the department of dermatology at the University of Texas Southwestern Medical Center. Dr. Pandya says this is the most exciting time for him as a dermatologist with new vitiligo medications on the market an …

Continue reading "Vitiligo Medical Treatment Advances | Expert Insights"

Disorders of Depigmentation: Focus on Vitiligo
vitiligo
by Emily Murphy, MD on
At the 2023 ODAC Dermatology, Aesthetic & Surgical Conference, we were lucky to learn about the management of vitiligo from the renowned researcher and clinician, Dr.  John Harris, Professor and Chair of Dermatology at the University of Massachusetts. When a new patient with vitiligo presents to my clinic, I always pull out my phone to consult Dr. Harris’ treatment protocol – I am sure I …

Continue reading "Disorders of Depigmentation: Focus on Vitiligo"

How to Diagnose and Treat Hypopigmentation with Dr. Hamzavi
hypopigmentation
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Iltefat Hamzavi, dermatologist with Henry Ford Health and associate professor of dermatology at Wayne State University School of Medicine. Dr. Hamzavi addresses how to diagnose and treat hypopigmentation, a catch-all for pigmentary conditions where the pigment is not too dark or complete …

Continue reading "How to Diagnose and Treat Hypopigmentation with Dr. Hamzavi"

Skin Enzymes – Friday Pop Quiz 8/19/2022
by NEXT STEPS IN DERM TEAM on
The medication that the FDA recently approved for the treatment of this condition inhibits the same enzymes as which of the following? A. Ruxolitinib B. Abrocitinib C. Apremilast D. Adalimumab E. Tofacitinib To find out the correct answer and read the explanation, click here.    Brought to you by our brand partner Derm In-Review.  A product of SanovaWorks. …

Continue reading "Skin Enzymes – Friday Pop Quiz 8/19/2022"